Accessibility: Skip TopNav
Palisade Bio, Inc.
Phase 2 ASCENTRA-CD clinical trial in patients with moderate to severe Crohn’s disease (CD)
Format
PNG
Source
Palisade Bio, Inc.
Downloads
Original
Large
Medium
Small